The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics

Stopped early · Phase 4

Conditions studied: Rotator Cuff Tear

In brief

Patients undergoing shoulder rotator cuff surgery in an outpatient setting are the focus of this study. The purpose of this study is to determine if the product EXPAREL® can be used as a safe alternative in shoulder surgery to pain pumps, while limiting narcotic use and providing appropriate postoperative pain control.

Key facts

Study ID

NCT03290196

Run by

Andrews Research & Education Foundation

People needed

13

Starts

2015-09-03

Expected to finish

2022-04-07

Last updated by the study team

2025-03-30

Who can join

Age: 18 and older, up to 72. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female
• 18-72 years of age
• Subjects scheduled to undergo a rotator cuff repair with a subacromial decompression by one of the protocol investigators

You may not qualify if…

• Planned concomitant glenoid labral repair
• Previous open shoulder surgery
• Neurological deficit or other disability involving the surgical extremity
• Anyone with a documented allergy to bupivicaine
• Subjects that are not mentally competent to give consent
• Pregnant women
• Subjects with an intolerance to hydrocodone or oxycodone and/or brand name equivalent combination medication

Where it is running

• Andrews Research & Education Foundation — Gulf Breeze, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.